Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

In this section
Photo of Glen T. Schumock

Glen T. Schumock

Dean, Office of the Dean

Contact Information

833 South Wood Street (874)
College of Pharmacy
Chicago, IL 60612

Phone: (312) 996-7961

Website: http://www.experts.scival.com/uic/expert.asp?n=Glen+Thomas+Schumock&u_id=1944

Education

  • PhD, Epidemiology, University of Illinois at Chicago, Chicago, IL, 2012
  • MBA, Health Services Administration, University of Illinois at Chicago, Chicago, Illinois, 1994
  • Fellowship in Pharmacy Practice Administration, University of Illinois at Chicago, Chicago, IL, 1992
  • ASHP Accredited Specialized Residency in Hospital Pharmacy Administration, University of Illinois and Michael Reese Hospitals, Chicago, IL, 1991
  • ASHP Accredited Residency in Hospital Pharmacy, University of Washington Hospital and Harborview Medical Center , Seattle, WA, 1989
  • PharmD, University of Washington, Seattle, Washington, 1989
  • BS, Pharmacy, Washington State University, Pullman, WA, 1987

Research Interests

Dr. Glen Schumock’s research interests include the economic impact, clinical effectiveness, and safety of pharmaceuticals and related services or policies.

Intellectual Contributions

Journal Article

  • Samp JC, Joo MJ, Schumock GT, Calip GS, Pickard AS, Lee TA. "Risk of Cardiovascular and Cerebrovascular Events in COPD Patients Treated With Long-Acting β2-Agonist Combined With a Long-Acting Muscarinic or Inhaled Corticosteroid". Annals of Pharmacotherapy. 2017;51(11):945-953. doi:10.1177/1060028017719716.
  • Schumock GT, Li EC, Wiest MD, Suda K, Stubbings J, Matusiak LM, Hunkler RJ, Vermeulen LC. "National trends in prescription drug expenditures and projections for 2017". American Journal of Health-System Pharmacy. 2017;74(15):1158-1173. doi:10.2146/ajhp170164.
  • Samp JC, Joo MJ, Schumock GT, Calip GS, Pickard AS, Lee TA. "Comparative Effectiveness of Long-Acting Beta2-Agonist Combined with a Long-Acting Muscarinic Antagonist or Inhaled Corticosteroid in Chronic Obstructive Pulmonary Disease". Pharmacotherapy. 2017;37(4):447-455. doi:10.1002/phar.1913.
  • Suda K, Halbur DJ, Hunkler RJ, Matusiak LM, Schumock GT. "Spending on Hepatitis C Antivirals in the United States, 2009–2015". Pharmacotherapy. 2017;37(1):65-70. doi:10.1002/phar.1865.
  • Lee WJ, Briars LA, Lee TA, Calip GS, Suda K, Schumock GT. "Use of Tumor Necrosis Factor-Alpha Inhibitors in Children and Young Adults With Juvenile Idiopathic Arthritis or Rheumatoid Arthritis". Pharmacotherapy. 2016;36(12):1201-1209. doi:10.1002/phar.1856.
  • Lee WJ, Briars LA, Lee TA, Calip GS, Suda K, Schumock GT. "Top-down Versus Step-up Prescribing Strategies for Tumor Necrosis Factor Alpha Inhibitors in Children and Young Adults with Inflammatory Bowel Disease". Inflammatory Bowel Diseases. 2016;22(10):2410-2417. doi:10.1097/MIB.0000000000000880.
  • Schumock GT, Li EC, Suda K, Wiest MD, Stubbings JA, Matusiak LM, Hunkler RJ, Vermeulen LC. "National trends in prescription drug expenditures and projections for 2016". American Journal of Health-System Pharmacy. 2016;73(14):1058-1075. doi:10.2146/ajhp160205.
  • Hartke P, Vermeulen LC, Hoffman JM, Shah ND, Doloresco F, Suda K, Li EC, Matusiak LM, Hunkler RJ, Schumock GT. "Accuracy of annual prescription drug expenditure forecasts in AJHP". American Journal of Health-System Pharmacy. 2015;72(19):1642-1648. doi:10.2146/ajhp140850.
  • Schumock GT, Li EC, Suda K, Wiest MD, Stubbings J, Matusiak LM, Hunkler RJ, Vermeulen LC. "National trends in prescription drug expenditures and projections for 2015.". American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2015;72(9):717-36. doi:10.2146/ajhp140849.
  • Lee WJ, Lee TA, Pickard AS, Shoaibi A, Schumock GT. "Using linked electronic data to validate algorithms for health outcomes in administrative databases". Journal of Comparative Effectiveness Research. 2015;4(4):359-366. doi:10.2217/cer.15.14.
  • Lee W, Lee TA, Pickard AS, Caskey RN, Schumock GT. "Drugs associated with adverse events in children and adolescents.". Pharmacotherapy. 2014;34(9):918-26. doi:10.1002/phar.1455.
  • Schumock GT, Li EC, Suda K, Matusiak LM, Hunkler RJ, Vermeulen LC, Hoffman JM. "National trends in prescription drug expenditures and projections for 2014.". American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2014;71(6):482-99. doi:10.2146/ajhp130767.
  • Dilokthornsakul P, Chaiyakunapruk N, Schumock GT, Lee TA. "Calendar time-specific propensity score analysis for observational data: a case study estimating the effectiveness of inhaled long-acting beta-agonist on asthma exacerbations.". Pharmacoepidemiology and drug safety. 2014;23(2):152-64. doi:10.1002/pds.3540.
  • Adimadhyam S, Schumock GT, Walton SM, Joo M, McKell J, Lee TA. "Risk of arrhythmias associated with ipratropium bromide in children, adolescents, and young adults with asthma: a nested case-control study.". Pharmacotherapy. 2014;34(4):315-23. doi:10.1002/phar.1336.
  • Sharma A, Ketteler M, Marshall TS, Khan SS, Schumock GT. "Comparative cost analysis of management of secondary hyperparathyroidism with paricalcitol or cinacalcet with low-dose vitamin D in hemodialysis patients.". Journal of medical economics. 2013;16(9):1129-36. doi:10.3111/13696998.2013.823092.
  • Walton SM, , Crawford SY, Donnelly AJ, Schumock GT. "Survey of pharmacy staffing levels and vacancy rates in small and rural hospitals in Illinois.". American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2013;70(16):1392-6. doi:10.2146/ajhp120455.
  • Crawford SY, Schumock GT, , Walton SM, Donnelly AJ. "Comparison of pharmacy services at critical access hospitals and other rural and small hospitals in Illinois.". American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2013;70(15):1313-21. doi:10.2146/ajhp120442.
  • Schumock GT, , Crawford SY, Walton SM, Donnelly AJ. "Pharmacy practice in small and rural hospitals in Illinois--2011.". American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2013;70(13):1144-52. doi:10.2146/ajhp120437.
  • Hoffman JM, Li E, Doloresco F, Matusiak L, Hunkler RJ, Shah ND, Vermeulen LC, Schumock GT. "Projecting future drug expenditures in U.S. nonfederal hospitals and clinics--2013.". American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2013;70(6):525-39. doi:10.2146/ajhp120759.
  • Nutescu EA, Bautista A, Gao W, Galanter WL, Schumock GT, Mody SH, Bookhart BK, . "Warfarin anticoagulation after total hip or total knee replacement: clinical and resource-utilization outcomes in a university-based antithrombosis clinic.". American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2013;70(5):423-30. doi:10.2146/ajhp120341.
  • Johnson ES, Bartman BA, Briesacher BA, Fleming NS, Gerhard T, Kornegay CJ, Nourjah P, Sauer B, Schumock GT, Sedrakyan A, Stürmer T, West SL, Schneeweiss S. "The incident user design in comparative effectiveness research". Pharmacoepidemiology and Drug Safety. 2013;22(1):1-6. doi:10.1002/pds.3334.
  • Johnson ES, Bartman BA, Briesacher BA, Fleming NS, Gerhard T, Kornegay CJ, Nourjah P, Sauer B, Schumock GT, Sedrakyan A, Stürmer T, West SL, Schneeweiss S. "The incident user design in comparative effectiveness research.". Pharmacoepidemiology and drug safety. 2013;22(1):1-6. doi:10.1002/pds.3334.
  • Touchette D, Masica AL, Dolor RJ, Schumock GT, Choi YK, Kim Y, Smith SR. "Safety-focused medication therapy management: a randomized controlled trial.". Journal of the American Pharmacists Association : JAPhA. 2012;52(5):603-12. doi:10.1331/JAPhA.2012.12036.
  • Schumock GT, Stayner LT, Valuck RJ, Joo MJ, Gibbons RD, Lee TA. "Risk of suicide attempt in asthmatic children and young adults prescribed leukotriene-modifying agents: a nested case-control study.". The Journal of allergy and clinical immunology. 2012;130(2):368-75. doi:10.1016/j.jaci.2012.04.035.
  • Dolor RJ, Masica AL, Touchette D, Smith SR, Schumock GT. "Patient safety-focused medication therapy management: challenges affecting future implementation.". The American journal of managed care. 2012;18(7):e238-44.
  • Samp JC, Schumock GT, Pickard AS. "Retracted publications in the drug literature.". Pharmacotherapy. 2012;32(7):586-95. doi:10.1002/j.1875-9114.2012.01100.x.
  • Hoffman JM, Li E, Doloresco F, Matusiak L, Hunkler RJ, Shah ND, Vermeulen LC, Schumock GT. "Projecting future drug expenditures--2012.". American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2012;69(5):405-21. doi:10.2146/ajhp110697.
  • Stein BD, Bautista A, Schumock GT, Lee TA, Charbeneau JT, Lauderdale DS, Naureckas ET, Meltzer DO, Krishnan JA. "The validity of International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis codes for identifying patients hospitalized for COPD exacerbations.". Chest. 2012;141(1):87-93. doi:10.1378/chest.11-0024.
  • Nutescu EA, Bathija S, Sharp L, Gerber BS, Schumock GT, Fitzgibbon ML. "Anticoagulation patient self-monitoring in the United States: considerations for clinical practice adoption.". Pharmacotherapy. 2011;31(12):1161-74. doi:10.1592/phco.31.12.1161.
  • Barnum DT, Walton SM, Shields KL, Schumock GT. "Measuring hospital efficiency with Data Envelopment Analysis: nonsubstitutable vs. substitutable inputs and outputs.". Journal of medical systems. 2011;35(6):1393-401. doi:10.1007/s10916-009-9416-0.
  • Pickard AS, Lee TA, Solem CT, Joo MJ, Schumock GT, Krishnan JA. "Prioritizing comparative-effectiveness research topics via stakeholder involvement: an application in COPD.". Clinical pharmacology and therapeutics. 2011;90(6):888-92. doi:10.1038/clpt.2011.237.
  • Tiryaki F, Nutescu EA, Hennenfent JA, Karageanes AM, Koesterer LJ, , Schumock GT. "Anticoagulation therapy for hospitalized patients: patterns of use, compliance with national guidelines, and performance on quality measures.". American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2011;68(13):1239-44. doi:10.2146/ajhp100543.
  • Schumock GT, Lee TA, Joo MJ, Valuck RJ, Stayner LT, Gibbons RD. "Association between leukotriene-modifying agents and suicide: what is the evidence?". Drug safety. 2011;34(7):533-44. doi:10.2165/11587260-000000000-00000.
  • Doloresco F, Fominaya C, Schumock GT, Vermeulen LC, Matusiak L, Hunkler RJ, Shah ND, Hoffman JM. "Projecting future drug expenditures: 2011.". American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2011;68(10):921-32. doi:10.2146/ajhp100712.
  • Barnum DT, Shields KL, Walton SM, Schumock GT. "Improving the efficiency of distributive and clinical services in hospital pharmacy.". Journal of medical systems. 2011;35(1):59-70. doi:10.1007/s10916-009-9341-2.
  • Schumock GT, Walton SM, Lee TA, Marx SE, Audhya P, Andress DL. "Comparative effectiveness of paricalcitol versus cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis.". Nephron. Clinical practice. 2011;117(2):c151-9. doi:10.1159/000319781.
  • Schumock GT, Gibbons RD, Lee TA, Joo MJ, Valuck RJ, Stayner LT. "Relationship between leukotriene-modifying agent prescriptions dispensed and rate of suicide deaths by county in the US.". Drug, healthcare and patient safety. 2011;3:47-52. doi:10.2147/DHPS.S23665.
  • Walton SM, Schumock GT, McLain DA. "Cost analysis of flavocoxid compared to naproxen for management of mild to moderate OA.". Current medical research and opinion. 2010;26(9):2253-61. doi:10.1185/03007995.2010.505545.
  • Yang Y, McBride MV, Rodvold KA, Tverdek F, Trese AM, Hennenfent J, Schiff G, , Schumock GT. "Hospital policies and practices on prevention and treatment of infections caused by methicillin-resistant Staphylococcus aureus.". American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2010;67(12):1017-24. doi:10.2146/ajhp090563.
  • Stein BD, Charbeneau JT, Lee TA, Schumock GT, Lindenauer PK, Bautista A, Lauderdale DS, Naureckas ET, Krishnan JA. "Hospitalizations for acute exacerbations of chronic obstructive pulmonary disease: how you count matters.". COPD. 2010;7(3):164-71. doi:10.3109/15412555.2010.481696.
  • Hoffman JM, Doloresco F, Vermeulen LC, Shah ND, Matusiak L, Hunkler RJ, Schumock GT. "Projecting future drug expenditures--2010.". American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2010;67(11):919-28. doi:10.2146/ajhp100068.
  • Anderson SV, Schumock GT. "Evaluation and justification of clinical pharmacy services.". Expert review of pharmacoeconomics & outcomes research. 2009;9(6):539-45. doi:10.1586/erp.09.57.
  • Schumock GT, Shields KL, Walton SM, Barnum DT. "Data envelopment analysis: a method for comparing hospital pharmacy productivity.". American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2009;66(18):1660-5. doi:10.2146/ajhp080420.
  • Lee TA, Schumock GT, Bartle B, Pickard AS. "Mortality risk in patients receiving drug regimens with theophylline for chronic obstructive pulmonary disease.". Pharmacotherapy. 2009;29(9):1039-53. doi:10.1592/phco.29.9.1039.
  • Lee TA, Wilke C, Joo M, Stroupe KT, Krishnan JA, Schumock GT, Pickard AS. "Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.". Archives of internal medicine. 2009;169(15):1403-10. doi:10.1001/archinternmed.2009.233.
  • Schumock GT, Pickard AS. "Comparative effectiveness research: Relevance and applications to pharmacy.". American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2009;66(14):1278-86. doi:10.2146/ajhp090150.
  • Hoffman JM, Shah ND, Vermeulen LC, Doloresco F, Martin PK, Blake S, Matusiak L, Hunkler RJ, Schumock GT. "Projecting future drug expenditures--2009.". American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2009;66(3):237-57. doi:10.2146/ajhp080636.
  • Perez A, Doloresco F, Hoffman JM, Meek PD, Touchette D, Vermeulen LC, Schumock GT. "ACCP: economic evaluations of clinical pharmacy services: 2001-2005.". Pharmacotherapy. 2009;29(1):128. doi:10.1592/phco.29.1.128.
  • Schumock GT, Andress DL, Marx SE, Sterz R, Joyce AT, Kalantar-Zadeh K. "Association of secondary hyperparathyroidism with CKD progression, health care costs and survival in diabetic predialysis CKD patients.". Nephron. Clinical practice. 2009;113(1):c54-61. doi:10.1159/000228076.
  • Walton SM, Schumock GT, Lee K, Alexander GC, Meltzer D, Stafford RS. "Prioritizing future research on off-label prescribing: results of a quantitative evaluation.". Pharmacotherapy. 2008;28(12):1443-52. doi:10.1592/phco.28.12.1443.
  • Schumock GT, Andress D, Marx SE, Sterz R, Joyce AT, Kalantar-Zadeh K. "Impact of secondary hyperparathyroidism on disease progression, healthcare resource utilization and costs in pre-dialysis CKD patients.". Current medical research and opinion. 2008;24(11):3037-48. doi:10.1185/03007990802437943 .
  • Pickard AS, Becker RC, Schumock GT, Frye CB. "Clopidogrel-associated bleeding and related complications in patients undergoing coronary artery bypass grafting.". Pharmacotherapy. 2008;28(3):376-92. doi:10.1592/phco.28.3.376.
  • DiDomenico RJ, Perez A, Schumann HM, Fontana DR, Kondos GT, Schumock GT. "Impact of treatment guidelines on clinical and economic outcomes of acute decompensated heart failure.". The Annals of pharmacotherapy. 2008;42(3):327-33. doi:10.1345/aph.1K496.
  • Hoffman JM, Shah ND, Vermeulen LC, Doloresco F, Grim P, Hunkler RJ, Hontz KM, Schumock GT. "Projecting future drug expenditures--2008.". American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2008;65(3):234-53. doi:10.2146/ajhp070629.
  • Schumock GT, Walton SM, Gupta SR, Cramer JA. "Cost analysis of divalproex sodium extended-release compared to valproic acid in the treatment of bipolar disorder.". Current medical research and opinion. 2007;23(8):1997-2004. doi:10.1185/030079907X210831.
  • Hutchinson RA, Schumock GT. "Need to develop a legal and ethical base for pharmaceutical care. 1994.". The Annals of pharmacotherapy. 2007;41(7):1281-3. doi:10.1345/aph.140064.
  • Vats V, Nutescu EA, , , Schumock GT. "Survey of hospitals for guidelines, policies, and protocols for anticoagulants.". American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2007;64(11):1203-8. doi:10.2146/ajhp060264.
  • Gupta SR, , Walton SM, Botticelli JT, Shields KL, Quad JE, Schumock GT. "Association between hospital size and pharmacy department productivity.". American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2007;64(9):937-44. doi:10.2146/ajhp060228.
  • Walton SM, Knapp KK, Miller L, Schumock GT. "Examination of state-level changes in the pharmacist labor market using Census data.". Journal of the American Pharmacists Association : JAPhA. 2007;47(3):348-57. doi:10.1331/JAPhA.2007.06081.
  • Schumock GT, Sprague SM. "Clinical and economic burden of fractures in patients with renal osteodystrophy.". Clinical nephrology. 2007;67(4):201-8.
  • Vats V, DiDomenico RJ, , , Schumock GT. "Hospital policies for treatment of acute decompensated heart failure.". The Annals of pharmacotherapy. 2007;41(4):562-7. doi:10.1345/aph.1H664.
  • Hoffman JM, Shah ND, Vermeulen LC, Schumock GT, Grim P, Hunkler RJ, Hontz KM. "Projecting future drug expenditures--2007.". American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2007;64(3):298-314. doi:10.2146/ajhp060545.
  • Gupta SR, , Walton SM, Botticelli JT, Shields KL, Quad JE, Schumock GT. "Monitoring of pharmacy staffing, workload, and productivity in community hospitals.". American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2006;63(18):1728-34. doi:10.2146/ajhp060012.
  • Hoffman JM, Shah ND, Vermeulen LC, Schumock GT, Grim P, Hunkler RJ, Hontz KM. "Projecting future drug expenditures--2006.". American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2006;63(2):123-38. doi:10.2146/ajhp050446.
  • McKoy JM, Lyons EA, Obadina E, Carson K, Pickard AS, Schellhammer P, McLeod D, Boyd CE, McWilliams N, Sartor O, Schumock GT, McCaffery K, Bennett CL. "Caveat medicus: consequences of federal investigations of marketing activities of pharmaceutical suppliers of prostate cancer drugs.". Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005;23(34):8894-905. doi:10.1200/JCO.2005.01.4605.
  • Wolf MS, Fitzner KA, Powell EF, McCaffrey KR, Pickard AS, McKoy JM, Lindenberg J, Schumock GT, Carson KR, Ferreira MR, Dolan NC, Bennett CL. "Costs and cost effectiveness of a health care provider-directed intervention to promote colorectal cancer screening among Veterans.". Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005;23(34):8877-83. doi:10.1200/JCO.2005.02.6278.
  • Nutescu EA, Park HY, Walton SM, Blackburn JC, Finley JM, Lewis RK, Schumock GT. "Factors that influence prescribing within a therapeutic drug class.". Journal of evaluation in clinical practice. 2005;11(4):357-65. doi:10.1111/j.1365-2753.2005.00545.x.
  • Pickard AS, Hung SY, McKoy JM, Witt WP, Arseven A, Sharifi R, Wu Z, Knight SJ, McWilliams N, Schumock GT, Bennett CL. "Opportunities for disease state management in prostate cancer.". Disease management : DM. 2005;8(4):235-44. doi:10.1089/dis.2005.8.235.
  • Bennett CL, Nebeker JR, Lyons EA, Samore MH, Feldman MD, McKoy JM, Carson KR, Belknap SM, Trifilio SM, Schumock GT, Yarnold PR, Davidson CJ, Evens AM, Kuzel TM, Parada JP, Cournoyer D, West DP, Sartor O, Tallman MS, Raisch DW. "The Research on Adverse Drug Events and Reports (RADAR) project.". JAMA. 2005;293(17):2131-40. doi:10.1001/jama.293.17.2131.
  • Calhoun EA, Schumock GT, McKoy JM, Pickard S, Fitzner KA, Heckinger EA, Powell EF, McCaffrey KR, Bennett CL. "Granulocyte colony--stimulating factor for chemotherapy-induced neutropenia in patients with small cell lung cancer : the 40% rule revisited.". PharmacoEconomics. 2005;23(8):767-75.
  • Pickard AS, Nau DP, McKercher PL, Schumock GT. "Importation of prescription medications: experiences, opinions, and intended behaviors of U.S. community pharmacists.". Journal of the American Pharmacists Association : JAPhA. 2004;44(6):666-72.
  • Schumock GT, Blackburn JC, Nutescu EA, Walton SM, Finley JM, Lewis RK. "Impact of prescribing guidelines for inpatient anticoagulation.". The Annals of pharmacotherapy. 2004;38(10):1570-5. doi:10.1345/aph.1E121.
  • Bennett CL, Luminari S, Nissenson AR, Tallman MS, Klinge SA, McWilliams N, McKoy JM, Kim B, Lyons EA, Trifilio SM, Raisch DW, Evens AM, Kuzel TM, Schumock GT, Belknap SM, Locatelli F, Rossert J, Casadevall N. "Pure red-cell aplasia and epoetin therapy.". The New England journal of medicine. 2004;351(14):1403-8. doi:10.1056/NEJMoa040528.
  • Nutescu EA, Pickard AS, Blackburn JC, Wittkowsky AK, Ansell J, Schumock GT. "Impact of oral direct thrombin inhibitors on anticoagulation clinics.". Pharmacotherapy. 2004;24(9):1204-12.
  • Arozullah AM, Calhoun EA, Wolf M, Finley DK, Fitzner KA, Heckinger EA, Gorby NS, Schumock GT, Bennett CL. "The financial burden of cancer: estimates from a study of insured women with breast cancer.". The journal of supportive oncology. 2004;2(3):271-8.
  • Schumock GT, Walton SM, Park HY, Nutescu EA, Blackburn JC, Finley JM, Lewis RK. "Factors that influence prescribing decisions.". The Annals of pharmacotherapy. 2004;38(4):557-62. doi:10.1345/aph.1D390.
  • DiDomenico RJ, Park HY, Southworth MR, Eyrich HM, Lewis RK, Finley JM, Schumock GT. "Guidelines for acute decompensated heart failure treatment.". The Annals of pharmacotherapy. 2004;38(4):649-60. doi:10.1345/aph.1D481.
  • Park HY, Schumock GT, Pickard AS, Akhras K. "A structured review of the relationship between microalbuminuria and cardiovascular events in patients with diabetes mellitus and hypertension.". Pharmacotherapy. 2003;23(12):1611-6.
  • Schumock GT, Nair VP, Finley JM, Lewis RK. "Penetration of medication safety technology in community hospitals.". Journal of medical systems. 2003;27(6):531-41.
  • Ladewski LA, Belknap SM, Nebeker JR, Sartor O, Lyons EA, Kuzel TC, Tallman MS, Raisch DW, Auerbach AR, Schumock GT, Kwaan HC, Bennett CL. "Dissemination of information on potentially fatal adverse drug reactions for cancer drugs from 2000 to 2002: first results from the research on adverse drug events and reports project.". Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003;21(20):3859-66. doi:10.1200/JCO.2003.04.537.
  • Schumock GT, Walton SM. "Expenditures for prescription drugs: too much or not enough?". Healthcare financial management : journal of the Healthcare Financial Management Association. 2003;57(10):34-8, 41.
  • Nutescu EA, Lewis RK, Finley JM, Schumock GT. "Hospital guidelines for use of low-molecular-weight heparins.". The Annals of pharmacotherapy. 2003;37(7-8):1072-81.
  • Bennett CL, Schumock GT. "Cost analyses of adjunct colony stimulating factors for older patients with acute myeloid leukaemia : can they improve clinical decision making?". Drugs & aging. 2003;20(7):479-83.
  • Bennett CL, Schumock GT, Desai AA, Kwaan HC, Raisch DW, Newlin R, Stadler W. "Thalidomide-associated deep vein thrombosis and pulmonary embolism.". The American journal of medicine. 2002;113(7):603-6.
  • Schumock GT, Nutescu EA, Walton SM, Arondekar BV, Lewis RK. "Survey of hospital policies regarding low-molecular-weight heparins.". American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2002;59(6):534-8.
  • Goldstein JL, Larson LR, Yamashita BD, Fain JM, Schumock GT. "Low molecular weight heparin versus unfractionated heparin in the colonoscopy peri-procedure period: a cost modeling study.". The American journal of gastroenterology. 2001;96(8):2360-6. doi:10.1111/j.1572-0241.2001.04046.x.
  • Schumock GT. "Methods to assess the economic outcomes of clinical pharmacy services.". Pharmacotherapy. 2000;20(10 Pt 2):243S-252S.
  • Scheife RT, Schumock GT, Burstein A, Gottwald MD, Luer MS. "Impact of Parkinson's disease and its pharmacologic treatment on quality of life and economic outcomes.". American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2000;57(10):953-62.
  • Murdock DK, Schumock GT, Kaliebe J, Olson K, Guenette AJ. "Clinical and cost comparison of ibutilide and direct-current cardioversion for atrial fibrillation and flutter.". The American journal of cardiology. 2000;85(4):503-6, A11.
  • Schumock GT, Michaud J, Guenette AJ. "Re-engineering: an opportunity to advance clinical practice in a community hospital.". American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 1999;56(19):1945-9.
  • Seeger JD, , Schumock GT. "Characteristics associated with ability to prevent adverse drug reactions in hospitalized patients.". Pharmacotherapy. 1998;18(6):1284-9.
  • Schumock GT. "Economic considerations in the treatment and management of Alzheimer's disease.". American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 1998;55 Suppl 2:S17-21.
  • Schumock GT, Kafka PS, Tormo VJ. "Design, construction, implementation, and cost of a hospital pharmacy cleanroom.". American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 1998;55(5):458-63.
  • Meek PD, McKeithan K, Schumock GT. "Economic considerations in Alzheimer's disease.". Pharmacotherapy. 1998;18(2 Pt 2):68-73; discussion 79-82.
  • Crawford SY, Gandhi SK, Seeger JD, Schumock GT, Lam NP, Stubbings J, Schoen MD. "Efficacy of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in the treatment of patients with hypercholesterolemia: a meta-analysis of clinical trials.". Clinical therapeutics. 1997;19(4):778-97.
  • Schumock GT, Meek PD, Ploetz PA, Vermeulen LC. "Economic evaluations of clinical pharmacy services--1988-1995. The Publications Committee of the American College of Clinical Pharmacy.". Pharmacotherapy. 1996;16(6):1188-208.
  • Schumock GT, Lam NP, Winkler SR, . "Pharmacoeconomic analysis of stress ulcer prophylaxis for critically ill patients.". PharmacoEconomics. 1996;9(5):455-65.
  • Seeger JD, Schumock GT, . "Estimating the rate of adverse drug reactions with capture-recapture analysis.". American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 1996;53(2):178-81.
  • Schumock GT, Seeger JD, . "Control charts to monitor rates of adverse drug reactions.". Hospital pharmacy. 1995;30(12):1088, 1091-2, 1095-6.
  • Schumock GT, Raber SR, Crawford SY, Naderer OJ, Rodvold KA. "National survey of once-daily dosing of aminoglycoside antibiotics.". Pharmacotherapy. 1995;15(2):201-9.
  • , Schumock GT, Kendzierski DL. "Meta-analysis of controlled trials of drug therapy in mild chronic asthma: the role of inhaled corticosteroids.". The Annals of pharmacotherapy. 1994;28(11):1285-9.
  • Schumock GT, Marwaha TR, McBride JM, Clark T. "Automated order-entry mechanisms to influence prescribing.". Topics in hospital pharmacy management / Aspen Systems Corporation. 1994;14(3):21-9.
  • Hutchinson RA, Schumock GT. "Need to develop a legal and ethical base for pharmaceutical care.". The Annals of pharmacotherapy. 1994;28(7-8):954-6.
  • Schumock GT, Crawford SY, Giusto DA, Hutchinson RA. "Evaluating the performance of clinical pharmacy faculty: putting the ACCP template to use.". Pharmacotherapy. 1993;13(6):668-72.
  • Schumock GT, Guenette AJ, Clark T, McBride JM. "Hospital mainframe computer documentation of pharmacist interventions.". Topics in hospital pharmacy management / Aspen Systems Corporation. 1993;13(2):16-24.
  • Schumock GT, Hutchinson RA, Bilek BA. "Comparison of two systems for documenting pharmacist interventions in patient care.". American journal of hospital pharmacy. 1992;49(9):2211-4.
  • Schumock GT, Manasse, Jr HR, Hutchinson RA. "Pharmaceutical services in rural hospitals in Illinois--1991.". American journal of hospital pharmacy. 1992;49(9):2187-92.
  • Schumock GT, Thornton JP. "Focusing on the preventability of adverse drug reactions.". Hospital pharmacy. 1992;27(6):538.
  • Schumock GT, Thornton JP, Witte KW. "Comparison of pharmacy-based concurrent surveillance and medical record retrospective reporting of adverse drug reactions.". American journal of hospital pharmacy. 1991;48(9):1974-6.
  • Schaff RL, Schumock GT, Nadzam DM. "Development of the Joint Commission's indicators for monitoring the medication use system.". Hospital pharmacy. 1991;26(4):326-9, 350.
  • Schumock GT, Martinez E. "Acute oculogyric crisis after administration of prochlorperazine.". Southern medical journal. 1991;84(3):407-8.
  • Schumock GT, Leister KA, Edwards D, Wareham PS, Burkhart VD. "Method for evaluating performance of clinical pharmacists.". American journal of hospital pharmacy. 1990;47(1):127-31.

Other

  • Fitzpatrick MA, Suda K, Evans CT, Hunkler RJ, Weaver F, Schumock GT. (2017). "Influence of drug class and healthcare setting on systemic antifungal expenditures in the United States, 2005-15". American Journal of Health-System Pharmacy. Vol. 74. Issue 14. Page(s) 1076-1083. https://api.elsevier.com/content/abstract/scopus_id/85024392214
  • Walton SM, Basu A, Mullahy J, Hong S, Schumock GT. (2017). "Measuring the Value of Pharmaceuticals in the US Health System". PharmacoEconomics. Vol. 35. Issue 1. https://api.elsevier.com/content/abstract/scopus_id/84992371965
  • Schumock GT, Vermeulen LC. (2017). "The Rising Cost of Prescription Drugs: Causes and Solutions". Pharmacotherapy. Vol. 37. Issue 1. Page(s) 9-11. https://api.elsevier.com/content/abstract/scopus_id/85006804257
  • Suda K, Hunkler RJ, Matusiak LM, Schumock GT. (2015). "Influenza antiviral expenditures and outpatient prescriptions in the United States, 2003-2012". Pharmacotherapy. Vol. 35. Issue 11. Page(s) 991-997. https://api.elsevier.com/content/abstract/scopus_id/84948133064
  • Walton SM, Schumock GT. (2014). "Should off-label drugs be included as comparators in pharmacoeconomic studies?". PharmacoEconomics. Vol. 32. Issue 11. Page(s) 1035-7.
  • Cavallari LH, Schumock GT. (2012). "Cost is not a barrier to implementing clopidogrel pharmacogenetics.". Pharmacotherapy. Vol. 32. Issue 4. Page(s) 299-303.
  • Walton SM, Schumock GT, Alexander GC, Meltzer D, Stafford RS. (2010). "Importance of distinguishing supported and unsupported off-label drug use.". Archives of internal medicine. Vol. 170. Issue 7. Page(s) 657-8; author reply 658.
  • Hoffman JM, Meek PD, Touchette D, Vermeulen LC, Schumock GT. (2009). "Transparent and reproducible reports of economic evaluations of clinical pharmacy services: a goal for the future?". American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. Vol. 66. Issue 5. Page(s) 442-3; author reply 443-4.
  • Masica AL, Touchette D, Dolor RJ, Schumock GT, Kliethermes MA, Rodgers PT, Craft JL, Choi YK, Lux LJ, Smith SR. (2008). "Evaluation of a Medication Therapy Management Program in Medicare Beneficiaries at High Risk of Adverse Drug Events: Study Methods". Advances in Patient Safety: New Directions and Alternative Approaches (Vol. 4: Technology and Medication Safety). Agency for Healthcare Research and Quality (US).
  • Stubbings J, Kliethermes MA, Schumock GT. (2005). "Medicare drug cards: where are the savings?". Journal of the American Pharmacists Association : JAPhA. Vol. 45. Issue 3. Page(s) 308, 311.
  • Pickard AS, Schumock GT. (2002). "Aspirin use may change cost-effectiveness of COX-2 inhibitors.". Archives of internal medicine. Vol. 162. Issue 22. Page(s) 2637-8; author reply 2638-9.
  • Schumock GT. (1999). "We've been shown the money, and we now know how to spend it.". Pharmacotherapy. Vol. 19. Issue 12. Page(s) 1349-51.
  • Schumock GT, Guenette AJ, Keys TV, Hutchinson RA. (1994). "Prescribing errors for patients about to be discharged from a university teaching hospital.". American journal of hospital pharmacy. Vol. 51. Issue 18. Page(s) 2288, 2290.

Conference Proceeding

  • Calip GS, Lee WJ, Lee TA, Schumock GT, Chiu BC ed. "Risk of Non-Hodgkin Lymphoma Following Treatment of Inflammatory Conditions with Tumor Necrosis Factor-Alpha Inhibitors" . Blood. December-3-2015.
  • Calip GS, Lee WJ, Lee TA, Schumock GT, Chiu BC ed. "Tumor Necrosis Factor-Alpha Inhibitor Medications for Inflammatory Conditions and Incidence of Multiple Myeloma" . Blood. December-3-2015.

Review Glen T. Schumock’s online CV

Top